BNP Paribas Asset Management’s Phibro Animal Health PAHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$32K Buy
579
+146
+34% +$6.95K ﹤0.01% 1884
2025
Q4
$16K Buy
433
+77
+22% +$3.13K ﹤0.01% 2017
2025
Q3
$14K Sell
356
-26
-7% -$859 ﹤0.01% 1527
2025
Q2
$10K Buy
+382
New +$8.33K ﹤0.01% 1778

Other funds holding PAHC

BNP Paribas Asset Management's PAHC Position: Q1 2026 in Review

BNP Paribas Asset Management increased its Phibro Animal Health (PAHC) stake by 34% in Q1 2026, buying an estimated $6.95K and bringing the position to 579 shares worth $32K. The position accounts for ﹤0.01% of the portfolio, ranked #1884.

BNP Paribas Asset Management first reported a position in PAHC in Q2 2025 and has held it in 4 quarters since. 257 funds tracked by Wall St. Rank hold PAHC as of Q1 2026.

  • BNP Paribas Asset Management held 579 shares of Phibro Animal Health worth $32K as of Q1 2026.
  • BNP Paribas Asset Management bought 146 Phibro Animal Health shares in Q1 2026, an estimated $6.95K.
  • Phibro Animal Health made up ﹤0.01% of BNP Paribas Asset Management's portfolio in Q1 2026, its #1884 holding.
  • BNP Paribas Asset Management first reported a position in Phibro Animal Health in Q2 2025 and has held it in 4 quarters since.
  • 257 funds tracked by Wall St. Rank held Phibro Animal Health as of Q1 2026.

Based on BNP Paribas Asset Management's 13F filing for Q1 2026, filed 14 May 2026.